Inhibitors of tyk2
US-2024425484-A1 · Dec 26, 2024 · US
US9695155B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9695155-B2 |
| Application number | US-201415101095-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 9, 2014 |
| Priority date | Dec 10, 2013 |
| Publication date | Jul 4, 2017 |
| Grant date | Jul 4, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed are compounds of Formula 1, including all stereoisomers, N-oxides, and salts thereof, wherein each Y 1 , Y 2 , Y 3 , Y 4 , Z, R 2 , m and R 3 are as defined in the disclosure. Also disclosed are compositions containing a compound of Formula 1 and methods for controlling undesired vegetation comprising contacting the undesired vegetation or its environment with an effective amount of a compound or a composition of the invention.
Opening claim text (preview).
What is claimed is: 1. A compound selected from a compound of Formula 1, N-oxides and salts thereof wherein each Y 1 , Y 2 , Y 3 and Y 4 is independently selected from the group consisting of N and CR 1 , provided no more than 3 of Y 1 , Y 2 , Y 3 and Y 4 are N; Z is selected from the group consisting of O and S; each R 1 is independently selected from the group consisting of hydrogen, halogen, cyano, nitro, SF 5 , CHO, C(═O)NH 2 , C(═S)NH 2 , SO 2 NH 2 , C 1 -C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 1 -C 4 haloalkyl, C 2 -C 4 haloalkenyl, C 2 -C 4 haloalkynyl, C 3 -C 6 cycloalkyl, C 3 -C 6 halocycloalkyl, C 4 -C 8 alkylcycloalkyl, C 4 -C 8 cycloalkylalkyl, C 2 -C 6 alkylcarbonyl, C 2 -C 6 haloalkylcarbonyl, C 2 -C 6 alkoxycarbonyl, C 3 -C 7 cycloalkylcarbonyl, C 2 -C 8 alkylaminocarbonyl, C 3 -C 10 dialkylaminocarbonyl, C 1 -C 4 alkoxy, C 3 -C 4 alkenyloxy, C 3 -C 4 alkynyloxy, C 1 -C 4 haloalkoxy, C 3 -C 4 haloalkenyloxy, C 3 -C 4 haloalkynyloxy, C 3 -C 6 cycloalkoxy, C 3 -C 6 halocycloalkoxy, C 4 -C 8 cycloalkylalkoxy, C 2 -C 6 alkoxyalkyl, C 2 -C 6 haloalkoxyalkyl, C 2 -C 6 alkoxyhaloalkyl, C 2 -C 6 alkoxyalkoxy, C 2 -C 4 alkylcarbonyloxy, C 2 -C 6 cyanoalkyl, C 2 -C 6 cyanoalkoxy, C 2 -C 4 alkylthioalkyl, SO n R 1A , Si(CH 3 ) 3 , B(—OC(R 1B ) 2 C(R 1B ) 2 O—); a phenyl ring optionally substituted with up to 5 substituents independently selected from R 1C ; and a 5- or 6-membered heteroaromatic ring containing ring members selected from carbon atoms and up to 4 heteroatoms independently selected from the group consisting of up to 2 O, up to 2 S and up to 4 N atoms, each ring optionally substituted with up to 3 substituents independently selected from R 1C on carbon atom ring members and R 1D on nitrogen atom ring members; R 2 is selected from the group consisting of halogen, cyano, nitro, C 1 -C 4 alkoxy, C 1 -C 4 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, SO n R 2A , C 1 -C 4 haloalkyl and C 3 -C 6 cycloalkyl; m is selected from the group consisting of 0, 1, 2 and 3; each R 3 is independently selected from the group consisting of halogen, cyano, hydroxy, nitro, amino, CHO, C(═O)NH 2 , C(═S)NH 2 , SO 2 NH 2 , C 1 -C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 1 -C 4 haloalkyl, C 2 -C 4 haloalkenyl, C 2 -C 4 haloalkynyl, C 3 -C 6 cycloalkyl, C 3 -C 6 halocycloalkyl, C 4 -C 8 alkylcycloalkyl, C 4 -C 8 cycloalkylalkyl, C 2 -C 6 alkylcarbonyl, C 2 -C 6 haloalkylcarbonyl, C 2 -C 6 alkoxycarbonyl, C 3 -C 7 cycloalkylcarbonyl, C 1 -C 4 alkoxy, C 3 -C 4 alkenyloxy, C 3 -C 4 alkynyloxy, C 1 -C 4 haloalkoxy, C 3 -C 4 haloalkenyloxy, C 3 -C 4 haloalkynyloxy, C 3 -C 6 cycloalkoxy, C 3 -C 6 halocycloalkoxy, C 4 -C 8 cycloalkylalkoxy, C 2 -C 6 alkoxyalkyl, C 2 -C 6 haloalkoxyalkyl, C 2 -C 6 alkoxyhaloalkyl, C 2 -C 6 alkoxyalkoxy, C 2 -C 4 alkylcarbonyloxy, C 2 -C 6 cyanoalkyl, C 2 -C 6 cyanoalkoxy, C 2 -C 4 alkylthioalkyl, Si(CH 3 ) 3 , C≡CSi(CH 3 ) 3 , C(═O)N(R 3A )(R 3B ), C(═NOR 3C )H, C(═NR 3D )H, SO n R 3E ; a phenyl ring optionally substituted with up to 5 substituents independently selected from R 3F ; a 5- or 6-membered heteroaromatic ring containing ring members selected from carbon atoms and up to 4 heteroatoms independently selected from the group consisting of up to 2 O, up to 2 S and up to 4 N atoms, each ring optionally substituted with up to 3 substituents independently selected from R 3F on carbon atom ring members and R 3G on nitrogen atom ring members; and pyrimidinyloxy; each n is independently selected from the group consisting of 0, 1 and 2; each R 1A , R 2A and R 3E is independently selected from the group consisting of C 1 -C 4 alkyl, C 1 -C 4 haloalkyl, C 1 -C 4 alkylamino and C 2 -C 6 dialkylamino; each R 1B is independently selected from the group consisting of H and C 1 -C 4 alkyl; each R 1C is independently selected from the group consisting of hydroxy, halogen, cyano, nitro, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 alkoxy and C 1 -C 6 haloalkoxy; each R 1D is independently selected from the group consisting of cyano, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 alkoxy and C 2 -C 6 alkylcarbonyl; each R 3A is independently selected from the group consisting of C 1 -C 4 alkyl and C 1 -C 4 haloalkyl; each R 3B is independently selected from the group consisting of H, C 1 -C 4 alkyl and C 1 -C 4 haloalkyl; each R 3C is independently selected from the group consisting of H and C 1 -C 4 alkyl; each R 3D is independently selected from the group consisting of H, amino, C 1 -C 4 alkyl and C 1 -C 4 alkylamino; each R 3F is independently selected from the group consisting of hydroxy, halogen, cyano, nitro, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 alkoxy and C 1 -C 6 haloalkoxy; and each R 3G is independently selected from the group consisting of cyano, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 alkoxy and C 2 -C 6 alkylcarbonyl; provided when i) Y 1 is N; Y 2 is CH; Y 3 is CBr; Y 4 is CH; and R 2 is Cl, then R 3 is other than 5-CF 3 , 5-CN or 5-NO 2 ; ii) Y 1 is N; Y 2 is CH; Y 3 is CBr; Y 4 is CH; and R 2 is Br, then R 3 is other than 5-CF 3 ; and iii) Y 1 is N; Y 2 is CCH 3 ; Y 3 is CCl; Y 4 is CCl; and R 2 is Cl, then m is other than 0. 2. A compound of claim 1 wherein —Y 1 ═Y 2 —Y 3 ═Y 4 — including the nitrogen to which Y 1 and Y 4 are both attached is selected from the group consisting of Z is O; each R 1 is independently selected from the group consisting of hydrogen, halogen, cyano, SF 5 , CHO, C 1 -C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 1 -C 4 haloalkyl, C 2 -C 4 haloalkenyl, C 2 -C 4 haloalkynyl, C 2 -C 6 alkylcarbonyl, C 2 -C 6 haloalkylcarbonyl, C 2 -C 6 alkoxycarbonyl, C 1 -C 4 alkoxy, C 3 -C 4 alkenyloxy, C 3 -C 4 alkynyloxy, C 1 -C 4 haloalkoxy, C 3 -C 4 haloalkenyloxy, C 3 -C 4 haloalkynyloxy, C 2 -C 6 alkoxyalkyl, C 2 -C 6 haloalkoxyalkyl, C 2 -C 6 cyanoalkyl, C 2 -C 4 alkylthioalkyl, SO n R 1A , Si(CH 3 ) 3 and B(—OC(R 1B ) 2 C(R 1B ) 2 O—); R 2 is selected from the group consisting of halogen, C 1 -C 4 alkyl and C 1 -C 4 haloalkyl; each R 3 is independently selected from the group consisting of halogen, cyano, CHO, C 1 -C 4 alkyl, C 2 -C 4 alkenyl, C 2 -C 4 alkynyl, C 1 -C 4 haloalkyl, C 2 -C 4 haloalkenyl, C 2 -C 4 haloalkynyl, C 3 -C 6 cycloalkyl, C 3 -C 6 halocycloalkyl, C 4 -C 8 alkylcycloalkyl, C 2 -C 6 alkylcarbonyl, C 2 -C 6 haloalkylcarbonyl, C 2 -C 6 alkoxycarbonyl, C 1 -C 4 alkoxy, C 3 -C 4 alkenyloxy, C 3 -C 4 alkynyloxy, C 1 -C 4 haloalkoxy, C 3 -C 4 haloalkenyloxy, C 3 -C 4 haloalkynyloxy, C 3 -C 6 cycloalkoxy, C 3 -C 6 halocycloalkoxy, C 2 -C 6 alkoxyalkyl, C 2 -C 6 haloalkoxyalkyl, C 2 -C 4 alkylcarbonyloxy, C 2 -C 6 cyanoalkyl, C(═O)N(R 3A )(R 3B ), C(═NOR 3C )H, SO n R 3E ; a phenyl ring optionally substituted with up to 5 substituents independently selected from R 3F ; and a 5- or 6-membered heteroaromatic ring containing ring members selected from carbon atoms and up to 4 heteroatoms independently selected from up to 2 O, up to 2 S and up to 4 N atoms, each ring optionally substituted with up to 3 substituents independently selected from R 3F on carbon atom ring members and R 3G on nitrogen atom ring members; and m is selected from the group consisting of 0, 1 and 2. 3. A compound of claim 2 wherein —Y 1 ═Y 2 —Y 3 ═Y 4 — including the nitrogen to which Y 1 and Y 4 are both attached i
1,3-Diazines; Hydrogenated 1,3-diazines · CPC title
1,2-Diazoles; Hydrogenated 1,2-diazoles · CPC title
Triazoles; Hydrogenated triazoles · CPC title
linked by a chain containing hetero atoms as chain links · CPC title
containing three or more hetero rings · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.